Mark Armanious, M.D.
NPI 1740600261 · Neurology Physician · Tampa, FL
Enrolled with Medicare as Practitioner - Neurology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1740600261
- Entity type
- Individual
- Primary specialty
- Neurology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
12 yrs in NPPES registry
- Profile completeness25% of score
83% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
250 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 48 | $173 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 41 | $124 |
| Injection of Chemical for Paralysis of Facial and Neck Nerve Muscles on Both Sides of Face64615 | 32 | $143 |
| Needle Measurement of Electrical Activity in Arm Or Leg Muscles, Complete Study95886 | 25 | $90 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 23 | $87 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'S |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 21 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Rizatriptan Benzoatebrand: Rizatriptan | 50 | 12 |
| Mycophenolate Mofetil | 46 | — |
| Ubrogepantbrand: Ubrelvy | 43 | — |
| Galcanezumab-Gnlmbrand: Emgality Pen | 41 | — |
| Prednisone | 41 | — |
| Atogepantbrand: Qulipta | 33 | — |
| Immun Glob G(igg)/Gly/Iga Ov50brand: Gammagard Liquid | 32 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,811 across 4 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2014-04-23
- Last updated
- 2021-03-22
- Certified
- 2021-03-22
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.